» Articles » PMID: 23361394

Induction of Hyperhomocysteinemia Models Vascular Dementia by Induction of Cerebral Microhemorrhages and Neuroinflammation

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular dementia (VaD) is the second leading cause of dementia behind Alzheimer's disease (AD) and is a frequent comorbidity with AD, estimated to occur in as many as 40% of AD patients. The causes of VaD are varied and include chronic cerebral hypoperfusion, microhemorrhages, hemorrhagic infarcts, or ischemic infarcts. We have developed a model of VaD by inducing hyperhomocysteinemia (HHcy) in wild-type mice. By placing wild-type mice on a diet deficient in folate, B6, and B12 and supplemented with excess methionine, we induced a moderate HHcy (plasma level homocysteine 82.93 ± 3.561 μmol). After 11 weeks on the diet, the hyperhomocysteinemic mice showed a spatial memory deficit as assessed by the 2-day radial-arm water maze. Also, magnetic resonance imaging and subsequent histology revealed significant microhemorrhage occurrence. We found neuroinflammation induced in the hyperhomocysteinemic mice as determined by elevated interleukin (IL)-1β, tumor necrosis factor (TNF)α, and IL-6 in brain tissue. Finally, we found increased expression and increased activity of the matrix metalloproteinase 2 (MMP2) and MMP9 systems that are heavily implicated in the pathogenesis of cerebral hemorrhage. Overall, we have developed a dietary model of VaD that will be valuable for studying the pathophysiology of VaD and also for studying the comorbidity of VaD with other dementias and other neurodegenerative disorders.

Citing Articles

Hyperhomocysteinemia-induced VCID results in visual deficits, reduced neuroinflammation and vascular alterations in the retina.

Weekman E, Rogers C, Sudduth T, Wilcock D J Neuroinflammation. 2025; 22(1):23.

PMID: 39885592 PMC: 11783940. DOI: 10.1186/s12974-025-03332-7.


Comprehensive predictive model for cerebral microbleeds: integrating clinical and biochemical markers.

Wang L, Li Y, Hu Y, Ling L, Jia N, Chen Y Front Neurosci. 2024; 18:1429088.

PMID: 39734492 PMC: 11671399. DOI: 10.3389/fnins.2024.1429088.


Glial 'omics in ischemia: Acute stroke and chronic cerebral small vessel disease.

McDonough A, Weinstein J Glia. 2024; 73(3):495-518.

PMID: 39463002 PMC: 11785505. DOI: 10.1002/glia.24634.


A small molecule p38α MAPK inhibitor, MW150, attenuates behavioral deficits and neuronal dysfunction in a mouse model of mixed amyloid and vascular pathologies.

Frazier H, Braun D, Bailey C, Coleman M, Davis V, Dundon S Brain Behav Immun Health. 2024; 40:100826.

PMID: 39161874 PMC: 11331815. DOI: 10.1016/j.bbih.2024.100826.


Caffeic acid protects against l-methionine induced reduction in neurogenesis and cognitive impairment in a rat model.

Sirichoat A, Dornlakorn O, Saenno R, Aranarochana A, Sritawan N, Pannangrong W Heliyon. 2024; 10(5):e26919.

PMID: 38455532 PMC: 10918208. DOI: 10.1016/j.heliyon.2024.e26919.


References
1.
Gorelick P, Scuteri A, Black S, DeCarli C, Greenberg S, Iadecola C . Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(9):2672-713. PMC: 3778669. DOI: 10.1161/STR.0b013e3182299496. View

2.
Ernest S, Hosack A, OBrien W, Rosenblatt D, Nadeau J . Homocysteine levels in A/J and C57BL/6J mice: genetic, diet, gender, and parental effects. Physiol Genomics. 2005; 21(3):404-10. DOI: 10.1152/physiolgenomics.00199.2004. View

3.
Wilcock D, Rojiani A, Rosenthal A, Subbarao S, Freeman M, Gordon M . Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation. 2004; 1(1):24. PMC: 539292. DOI: 10.1186/1742-2094-1-24. View

4.
Roman G . Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention. Med Clin North Am. 2002; 86(3):477-99. DOI: 10.1016/s0025-7125(02)00008-1. View

5.
Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D . Cognitive impairment and vitamin B12: a review. Int Psychogeriatr. 2012; 24(4):541-56. DOI: 10.1017/S1041610211002511. View